{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:55:42Z","timestamp":1793465742779,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Key Research and Development Program of China is a major national initiative that funds strategic, cutting-edge scientific research and technological development projects."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41591-026-04605-1","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:02:12Z","timestamp":1787130132000},"page":"3331-3338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4550-4557","authenticated-orcid":false,"given":"He","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-4064","authenticated-orcid":false,"given":"Phlippe","family":"Menasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9672-2604","authenticated-orcid":false,"given":"Jiaxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-2526","authenticated-orcid":false,"given":"Dongjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"4605_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan, M. S. et al. Global epidemiology of heart failure. Nat. Rev. Cardiol. 21, 717\u2013734 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"4605_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","volume":"31","author":"B Bozkurt","year":"2025","unstructured":"Bozkurt, B. et al. HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America. J. Card. Fail. 31, 66\u2013116 (2025).","journal-title":"J. Card. Fail."},{"key":"4605_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jchf.2021.05.009","volume":"9","author":"SM Dunlay","year":"2021","unstructured":"Dunlay, S. M. et al. Advanced heart failure epidemiology and outcomes: a population-based study. JACC Heart Fail. 9, 722\u2013732 (2021).","journal-title":"JACC Heart Fail."},{"key":"4605_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.hfc.2021.06.002","volume":"17","author":"MG Crespo-Leiro","year":"2021","unstructured":"Crespo-Leiro, M. G. & Barge-Caballero, E. Advanced heart failure: definition, epidemiology, and clinical course. Heart Fail. Clin. 17, 533\u2013545 (2021).","journal-title":"Heart Fail. Clin."},{"key":"4605_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01098-8","author":"JJ Zhang","year":"2024","unstructured":"Zhang, J. J. et al. Trials and tribulations of cell therapy for heart failure: an update on ongoing trials. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-024-01098-8 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"4605_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cardfail.2022.10.433","volume":"29","author":"Y Kishino","year":"2023","unstructured":"Kishino, Y. et al. Cardiac regenerative therapy using human pluripotent stem cells for heart failure: a state-of-the-art review. J. Card. Fail. 29, 503\u2013513 (2023).","journal-title":"J. Card. Fail."},{"key":"4605_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-020-01602-0","volume":"11","author":"X Guan","year":"2020","unstructured":"Guan, X. et al. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts. Stem Cell Res. Ther. 11, 73 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"4605_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s13287-025-04664-0","volume":"16","author":"X Guan","year":"2025","unstructured":"Guan, X. et al. Human induced pluripotent stem cell-derived cardiomyocytes improve recovery from myocardial infarction in non-human primates. Stem Cell Res. Ther. 16, 581 (2025).","journal-title":"Stem Cell Res. Ther."},{"key":"4605_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/d41586-020-01285-w","volume":"581","author":"S Mallapaty","year":"2020","unstructured":"Mallapaty, S. \u2018Reprogrammed\u2019 stem cells for heart disease tested in China. Nature 581, 249\u2013250 (2020).","journal-title":"Nature"},{"key":"4605_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacbts.2025.01.007","volume":"10","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Reviving hearts, restoring lives: long-term outcomes of allogeneic iPSC-cardiomyocytes transplantation for advanced heart failure patients. JACC Basic Transl. Sci. 10, 253\u2013255 (2025).","journal-title":"JACC Basic Transl. Sci."},{"key":"4605_CR11","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","volume":"16","author":"K Nakamura","year":"2021","unstructured":"Nakamura, K. et al. Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes. Stem Cell Rep. 16, 2473\u20132487 (2021).","journal-title":"Stem Cell Rep."},{"key":"4605_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.stem.2024.12.005","volume":"32","author":"A Kirkeby","year":"2025","unstructured":"Kirkeby, A., Main, H. & Carpenter, M. Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update. Cell Stem Cell 32, 10\u201337 (2025).","journal-title":"Cell Stem Cell"},{"key":"4605_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9, P. et al. Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 71, 429\u2013438 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4605_CR14","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.7150\/thno.19427","volume":"7","author":"K Ban","year":"2017","unstructured":"Ban, K., Bae, S. & Yoon, Y.-S. Current strategies and challenges for purification of cardiomyocytes derived from human pluripotent Stem Cells. Theranostics 7, 2067\u20132077 (2017).","journal-title":"Theranostics"},{"key":"4605_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcyt.2019.10.001","volume":"21","author":"Y Sato","year":"2019","unstructured":"Sato, Y. et al. Tumorigenicity assessment of cell therapy products: the need for global consensus and points to consider. Cytotherapy 21, 1095\u20131111 (2019).","journal-title":"Cytotherapy"},{"key":"4605_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamacardio.2016.2750","volume":"1","author":"PK Nguyen","year":"2016","unstructured":"Nguyen, P. K., Neofytou, E., Rhee, J.-W. & Wu, J. C. Potential Strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review. JAMA Cardiol 1, 953\u2013962 (2016).","journal-title":"JAMA Cardiol"},{"key":"4605_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJH Chong","year":"2014","unstructured":"Chong, J. J. H. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273\u2013277 (2014).","journal-title":"Nature"},{"key":"4605_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"Y-W Liu","year":"2018","unstructured":"Liu, Y.-W. et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat. Biotechnol. 36, 597\u2013605 (2018).","journal-title":"Nat. Biotechnol."},{"key":"4605_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","volume":"538","author":"Y Shiba","year":"2016","unstructured":"Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388\u2013391 (2016).","journal-title":"Nature"},{"key":"4605_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","volume":"12","author":"R Romagnuolo","year":"2019","unstructured":"Romagnuolo, R. et al. Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Rep. 12, 967\u2013981 (2019).","journal-title":"Stem Cell Rep."},{"key":"4605_CR21","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1253\/circj.CJ-20-0755","volume":"84","author":"Y Shiba","year":"2020","unstructured":"Shiba, Y. Pluripotent stem cells for cardiac regeneration\u2014current status, challenges, and future perspectives. Circ. J. 84, 2129\u20132135 (2020).","journal-title":"Circ. J."},{"key":"4605_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.stemcr.2024.06.012","volume":"19","author":"T St\u00fcdemann","year":"2024","unstructured":"St\u00fcdemann, T. et al. Impulse initiation in engrafted pluripotent stem cell-derived cardiomyocytes can stimulate the recipient heart. Stem Cell Rep. 19, 1053\u20131060 (2024).","journal-title":"Stem Cell Rep."},{"key":"4605_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68373-9","volume":"10","author":"H Ichimura","year":"2020","unstructured":"Ichimura, H. et al. Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo. Sci. Rep. 10, 11883 (2020).","journal-title":"Sci. Rep."},{"key":"4605_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/cvr\/cvab115","volume":"118","author":"D Thomas","year":"2022","unstructured":"Thomas, D., Cunningham, N. J., Shenoy, S. & Wu, J. C. Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production. Cardiovasc. Res. 118, 20\u201336 (2022).","journal-title":"Cardiovasc. Res."},{"key":"4605_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","volume":"639","author":"A-F Jebran","year":"2025","unstructured":"Jebran, A.-F. et al. Engineered heart muscle allografts for heart repair in primates and humans. Nature 639, 503\u2013511 (2025).","journal-title":"Nature"},{"key":"4605_CR26","doi-asserted-by":"publisher","first-page":"e0131446","DOI":"10.1371\/journal.pone.0131446","volume":"10","author":"KA Gerbin","year":"2015","unstructured":"Gerbin, K. A., Yang, X., Murry, C. E. & Coulombe, K. L. K. Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS ONE 10, e0131446 (2015).","journal-title":"PLoS ONE"},{"key":"4605_CR27","first-page":"e272","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib, S. M. et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. Circulation 138, e272\u2013e391 (2018).","journal-title":"Circulation"},{"key":"4605_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse, T. et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat. Biotechnol. 37, 252\u2013258 (2019).","journal-title":"Nat. Biotechnol."},{"key":"4605_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.stem.2024.05.005","volume":"31","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques. Cell Stem Cell 31, 974\u2013988.e5 (2024).","journal-title":"Cell Stem Cell"},{"key":"4605_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","volume":"122","author":"K Zhu","year":"2018","unstructured":"Zhu, K. et al. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ. Res. 122, 958\u2013969 (2018).","journal-title":"Circ. Res."},{"key":"4605_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3727\/096368915X688551","volume":"25","author":"Y Li","year":"2016","unstructured":"Li, Y., Li, D. & Raisman, G. Functional repair of rat corticospinal tract lesions does not require permanent survival of an immunoincompatible transplant. Cell Transplant. 25, 293\u2013299 (2016).","journal-title":"Cell Transplant."},{"key":"4605_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12445","volume":"13","author":"H Gonz\u00e1lez-King","year":"2024","unstructured":"Gonz\u00e1lez-King, H. et al. Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: superiority of embryonic stem cells. J. Extracell. Vesicles 13, e12445 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"4605_CR33","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","volume":"121","author":"A Tachibana","year":"2017","unstructured":"Tachibana, A. et al. Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium. Circ. Res. 121, e22\u2013e36 (2017).","journal-title":"Circ. Res."},{"key":"4605_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/hrt.2006.089656","volume":"93","author":"C Raphael","year":"2007","unstructured":"Raphael, C. et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93, 476\u2013482 (2007).","journal-title":"Heart"},{"key":"4605_CR35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.CIR.64.6.1227","volume":"64","author":"L Goldman","year":"1981","unstructured":"Goldman, L., Hashimoto, B., Cook, E. F. & Loscalzo, A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64, 1227\u20131234 (1981).","journal-title":"Circulation"},{"key":"4605_CR36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/ehjci\/jes104","volume":"13","author":"AFL Schinkel","year":"2012","unstructured":"Schinkel, A. F. L. et al. Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing. Eur. Heart J. Cardiovasc. Imaging 13, 900\u2013904 (2012).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"4605_CR37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1148\/radiol.2531082137","volume":"252","author":"C Uebleis","year":"2009","unstructured":"Uebleis, C. et al. Stable coronary artery disease: prognostic value of myocardial perfusion SPECT in relation to coronary calcium scoring\u2014long-term follow-up. Radiology 252, 682\u2013690 (2009).","journal-title":"Radiology"},{"key":"4605_CR38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2967\/jnumed.108.055954","volume":"50","author":"A Gimelli","year":"2009","unstructured":"Gimelli, A. et al. Stress\/rest myocardial perfusion abnormalities by gated SPECT: still the best predictor of cardiac events in stable ischemic heart disease. J. Nucl. Med. 50, 546\u2013553 (2009).","journal-title":"J. Nucl. Med."},{"key":"4605_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/eurheartj\/ehq389","volume":"32","author":"EC Adelstein","year":"2011","unstructured":"Adelstein, E. C. et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur. Heart J. 32, 93\u2013103 (2011).","journal-title":"Eur. Heart J."},{"key":"4605_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.15283\/ijsc20075","volume":"13","author":"AT Ulus","year":"2020","unstructured":"Ulus, A. T. et al. Intramyocardial transplantation of umbilical cord mesenchymal stromal cells in chronic ischemic cardiomyopathy: a controlled, randomized clinical trial (HUC-HEART Trial). Int. J. Stem Cells 13, 364\u2013376 (2020).","journal-title":"Int. J. Stem Cells"},{"key":"4605_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.healun.2014.02.009","volume":"33","author":"T P\u00e4til\u00e4","year":"2014","unstructured":"P\u00e4til\u00e4, T. et al. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J. Heart Lung Transplant. 33, 567\u2013574 (2014).","journal-title":"J. Heart Lung Transplant."},{"key":"4605_CR42","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.jacc.2024.08.069","volume":"84","author":"JW Cunningham","year":"2024","unstructured":"Cunningham, J. W. et al. Artificial intelligence in cardiovascular clinical trials. J. Am. Coll. Cardiol. 84, 2051\u20132062 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4605_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3522","author":"EC Perin","year":"2024","unstructured":"Perin, E. C. et al. Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF. Eur. J. Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3522 (2024).","journal-title":"Eur. J. Heart Fail."},{"key":"4605_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ebiom.2019.09.043","volume":"48","author":"AC Rieger","year":"2019","unstructured":"Rieger, A. C. et al. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy. EBioMedicine 48, 377\u2013385 (2019).","journal-title":"EBioMedicine"},{"key":"4605_CR45","unstructured":"Guidance for industry\u2014characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. FDA https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/characterization-and-qualification-cell-substrates-and-other-biological-materials-used-production (2010)."},{"key":"4605_CR46","doi-asserted-by":"publisher","unstructured":"Bhattacharya, S. et al. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52010 (2014).","DOI":"10.3791\/52010"},{"key":"4605_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127\u2013137 (2013).","journal-title":"Cell Stem Cell"},{"key":"4605_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijcard.2022.01.035","volume":"353","author":"E Donal","year":"2022","unstructured":"Donal, E., L\u2019official, G. & Kosmala, W. New guidelines for managing chronic heart failure patients and new needs in echocardiography. Int. J. Cardiol. 353, 71\u201372 (2022).","journal-title":"Int. J. Cardiol."},{"key":"4605_CR49","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","volume":"6","author":"CJ Rush","year":"2021","unstructured":"Rush, C. J. et al. Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiol. 6, 1130\u20131143 (2021).","journal-title":"JAMA Cardiol."},{"key":"4605_CR50","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s12350-018-1283-y","volume":"25","author":"S Dorbala","year":"2018","unstructured":"Dorbala, S. et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J. Nucl. Cardiol. 25, 1784\u20131846 (2018).","journal-title":"J. Nucl. Cardiol."},{"key":"4605_CR51","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2967\/jnumed.121.262432","volume":"63","author":"J Mhlanga","year":"2022","unstructured":"Mhlanga, J. et al. 18F-FDG PET in myocardial viability assessment: a practical and time-efficient protocol. J. Nucl. Med. 63, 602\u2013608 (2022).","journal-title":"J. Nucl. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04605-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:02:51Z","timestamp":1789480971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04605-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7414031\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W. is a scientific founder and equity holder in HELP Therapeutics. P.M. is a medical consultant for HELP Therapeutics. Q.W., J.F., C.L., Y. Xu and A.Z. are current employees of HELP Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}